Department of Surgery
Piyush Agarwal is a urologic surgeon who specializes in the multidisciplinary management of bladder cancer, using such complex surgical techniques as robotic and open radical cystectomy and continent urinary diversions, to treat his patients. His clinical and laboratory research focuses primarily on bladder cancer, specifically Bacillus Calmette-Guérin (BCG)–unresponsive disease, the urinary microbiome, molecular targeted therapy, and immunotherapy.
An expert in urologic cancer, he served on the Food and Drug Administration’s oncologic drug advisory committee. His research has been published in the Journal of Urology, Primary Care Reports, International Journal of Impotence Research, and Ultrasound Clinics. He also is an associate editor for the journal Bladder Cancer.
Agarwal received his MD from Weill Cornell Medicine, as well as a BA in biology and a BS in economics from the University of Pennsylvania. He completed his urology residency at Case Western Reserve University in Cleveland, followed by a fellowship in urologic oncology at The University of Texas MD Anderson Cancer Center. Before coming to the University of Chicago, he was a tenure-track investigator and head of the Bladder Cancer Section in the Urologic Oncology Branch of the National Cancer Institute at the National Institutes of Health.